Positive CHMP opinion for Javlor

The CHMP has issued a positive opinion recommending EU marketing authorisation for Javlor from Laboratoires Pierre Fabre. The drug has been recommended for...

EU lung cancer approval for Alimta

Alimta (pemetrexed for injection) has become the first agent approved in Europe as maintenance therapy for advanced, nonsquamous non-small cell lung cancer. The European...

Scientists recognised for Alzheimer’s research

Four scientists have been recognized by the Alzheimer’s Association for their extraordinary achievements in advancing Alzheimer's research at its 2009 International Conference on Alzheimer's...

Big pharma goes legally blonde

Reese Witherspoon is to produce and star in a new comedy about a woman’s career within the drug industry. Currently under development by Universal...

Security,Opportunity,Success: how Ashfield In2Focus can help you build a career

Pharmaceutical companies are downsizing, but one UK company keeps getting bigger. Ashfield In2Focus shows how its commitment to personal and professional development is providing...

Latest articles

R&D spending in the UK pharmaceutical sector has jumped 6.9% annually

R&D spending in the UK pharmaceutical sector has jumped 6.9% annually

Analysis of the latest ONS data by R&D tax relief specialists Catax shows that R&D spending in the UK pharmaceutical sector has jumped 6.9%...
New COVID-19 screening technology could test large groups with rapid response

New COVID-19 screening technology could test large groups with rapid response

The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...
Scaling up a Covid-19 vaccine

Distribution and scaling up a Covid-19 vaccine

The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Scaling up a Covid-19 vaccine

Distribution and scaling up a Covid-19 vaccine

The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
New COVID-19 screening technology could test large groups with rapid response

New COVID-19 screening technology could test large groups with rapid response

The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription